Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control
8
1
3
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 8 trials
100.0%
+13.5% vs industry average
50%
4 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
Treatment of Clonorchiasis in Guangxi With Albendazole, Tribendimidine, and Praziquantel
Role: collaborator
Phase III Clinical Trial of Quadrivalent Influenza Virus Split Vaccine
Role: collaborator
Phase I Clinical Trial of Quadrivalent Influenza Virus Split Vaccine
Role: collaborator
ResIlience-based Stigma REdUction Program ("Rise-up")
Role: collaborator
Theory-based HIV Disclosure Intervention for Parents
Role: collaborator
Shortened Regimens for Drug-susceptible Pulmonary Tuberculosis
Role: collaborator
Randomized Controlled Trial for Immunogenicity and Safety Evaluation of Bivalent Types 1 and 3 Oral Poliovirus Vaccine
Role: lead
The Clinical Trial Protocol for the Inactivated Poliomyelitis Vaccine Made From Sabin Strains
Role: collaborator
All 8 trials loaded